131 related articles for article (PubMed ID: 26666190)
1. Protective efficacy of IFN-ω AND IFN-λs against influenza viruses in induced A549 cells.
Škorvanová L; Švančarová P; Svetlíková D; Betáková T
Acta Virol; 2015 Dec; 59(4):413-7. PubMed ID: 26666190
[TBL] [Abstract][Full Text] [Related]
2. Influenza A virus replication is inhibited in IFN-λ2 and IFN-λ3 transfected or stimulated cells.
Svetlikova D; Kabat P; Ohradanova A; Pastorek J; Betakova T
Antiviral Res; 2010 Dec; 88(3):329-33. PubMed ID: 20969894
[TBL] [Abstract][Full Text] [Related]
3. Generation and characterization of interferon-lambda 1-resistant H1N1 influenza A viruses.
Ilyushina NA; Lugovtsev VY; Samsonova AP; Sheikh FG; Bovin NV; Donnelly RP
PLoS One; 2017; 12(7):e0181999. PubMed ID: 28750037
[TBL] [Abstract][Full Text] [Related]
4. In vitro anti-influenza A activity of interferon (IFN)-λ1 combined with IFN-β or oseltamivir carboxylate.
Ilyushina NA; Donnelly RP
Antiviral Res; 2014 Nov; 111():112-20. PubMed ID: 25245230
[TBL] [Abstract][Full Text] [Related]
5. Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons.
Osterlund P; Pirhonen J; Ikonen N; Rönkkö E; Strengell M; Mäkelä SM; Broman M; Hamming OJ; Hartmann R; Ziegler T; Julkunen I
J Virol; 2010 Feb; 84(3):1414-22. PubMed ID: 19939920
[TBL] [Abstract][Full Text] [Related]
6. Activation of type I and III interferon signalling pathways occurs in lung epithelial cells infected with low pathogenic avian influenza viruses.
Sutejo R; Yeo DS; Myaing MZ; Hui C; Xia J; Ko D; Cheung PC; Tan BH; Sugrue RJ
PLoS One; 2012; 7(3):e33732. PubMed ID: 22470468
[TBL] [Abstract][Full Text] [Related]
7. Pandemic 2009 H1N1 influenza virus is resistant to the antiviral activity of several interferon alpha subtypes.
Scagnolari C; Trombetti S; Soldà A; Selvaggi C; Monteleone K; Spano L; Pierangeli A; Clementi M; Turriziani O; Antonelli G
J Interferon Cytokine Res; 2011 Jun; 31(6):475-9. PubMed ID: 21235413
[TBL] [Abstract][Full Text] [Related]
8. Comparison of transcriptional profiles of interferons, CXCL10 and RIG-1 in influenza infected A549 cells stimulated with exogenous interferons.
Lachová V; Škorvanová L; Svetlíková D; Turianová L; Kostrábová A; Betáková T
Acta Virol; 2017; 61(2):183-190. PubMed ID: 28523924
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic changes mediated by microRNA miR29 activate cyclooxygenase 2 and lambda-1 interferon production during viral infection.
Fang J; Hao Q; Liu L; Li Y; Wu J; Huo X; Zhu Y
J Virol; 2012 Jan; 86(2):1010-20. PubMed ID: 22072783
[TBL] [Abstract][Full Text] [Related]
10. Low-dose interferon Type I treatment is effective against H5N1 and swine-origin H1N1 influenza A viruses in vitro and in vivo.
Haasbach E; Droebner K; Vogel AB; Planz O
J Interferon Cytokine Res; 2011 Jun; 31(6):515-25. PubMed ID: 21323570
[TBL] [Abstract][Full Text] [Related]
11. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo.
Ank N; West H; Bartholdy C; Eriksson K; Thomsen AR; Paludan SR
J Virol; 2006 May; 80(9):4501-9. PubMed ID: 16611910
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of type I and type III interferons against porcine reproductive and respiratory syndrome virus (PRRSV).
Luo R; Fang L; Jin H; Jiang Y; Wang D; Chen H; Xiao S
Antiviral Res; 2011 Aug; 91(2):99-101. PubMed ID: 21569798
[TBL] [Abstract][Full Text] [Related]
13. Casein Kinase 1α Mediates the Degradation of Receptors for Type I and Type II Interferons Caused by Hemagglutinin of Influenza A Virus.
Xia C; Wolf JJ; Vijayan M; Studstill CJ; Ma W; Hahm B
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343571
[TBL] [Abstract][Full Text] [Related]
14. Alpha/beta interferon (IFN-alpha/beta)-independent induction of IFN-lambda1 (interleukin-29) in response to Hantaan virus infection.
Stoltz M; Klingström J
J Virol; 2010 Sep; 84(18):9140-8. PubMed ID: 20592090
[TBL] [Abstract][Full Text] [Related]
15. Properties of H7N7 influenza A virus strain SC35M lacking interferon antagonist NS1 in mice and chickens.
Kochs G; Koerner I; Thiel L; Kothlow S; Kaspers B; Ruggli N; Summerfield A; Pavlovic J; Stech J; Staeheli P
J Gen Virol; 2007 May; 88(Pt 5):1403-1409. PubMed ID: 17412966
[TBL] [Abstract][Full Text] [Related]
16. The NF-kappaB inhibitor SC75741 protects mice against highly pathogenic avian influenza A virus.
Haasbach E; Reiling SJ; Ehrhardt C; Droebner K; Rückle A; Hrincius ER; Leban J; Strobl S; Vitt D; Ludwig S; Planz O
Antiviral Res; 2013 Sep; 99(3):336-44. PubMed ID: 23811282
[TBL] [Abstract][Full Text] [Related]
17. Differential RNA silencing suppression activity of NS1 proteins from different influenza A virus strains.
de Vries W; Haasnoot J; Fouchier R; de Haan P; Berkhout B
J Gen Virol; 2009 Aug; 90(Pt 8):1916-1922. PubMed ID: 19369407
[TBL] [Abstract][Full Text] [Related]
18. H7N9 and other pathogenic avian influenza viruses elicit a three-pronged transcriptomic signature that is reminiscent of 1918 influenza virus and is associated with lethal outcome in mice.
Morrison J; Josset L; Tchitchek N; Chang J; Belser JA; Swayne DE; Pantin-Jackwood MJ; Tumpey TM; Katze MG
J Virol; 2014 Sep; 88(18):10556-68. PubMed ID: 24991006
[TBL] [Abstract][Full Text] [Related]
19. Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model.
Bartlett NW; Buttigieg K; Kotenko SV; Smith GL
J Gen Virol; 2005 Jun; 86(Pt 6):1589-1596. PubMed ID: 15914836
[TBL] [Abstract][Full Text] [Related]
20. A Promising IFN-Deficient System to Manufacture IFN-Sensitive Influenza Vaccine Virus.
Chen C; Fan W; Li J; Zheng W; Zhang S; Yang L; Liu D; Liu W; Sun L
Front Cell Infect Microbiol; 2018; 8():127. PubMed ID: 29765910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
